2. Academic Validation
  3. Correction: HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy

Correction: HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy

  • Front Immunol. 2025 Aug 5:16:1645773. doi: 10.3389/fimmu.2025.1645773.
Valeria Spadotto # 1,  Chiara Ripamonti # 1,  Andrea Ghiroldi 1,  Elisabetta Galbiati 2,  Pietro Pozzi 2,  Roberta Noberini 3,  Tiziana Bonaldi 3 4,  Christian Steinkühler 1,  Gianluca Fossati 1
Affiliations

Affiliations

  • 1 New Drug Incubator Department, Italfarmaco Group, Milan, Italy.
  • 2 Preclinical Drug Development Department, Italfarmaco Group, Milan, Italy.
  • 3 Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • 4 Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy.
  • # Contributed equally.
PMID: 40837583 DOI: 10.3389/fimmu.2025.1645773
Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1546939.].

Keywords

HDAC6; TNF-α; dendritic cells; immuno-checkpoints; monocytes.

Figures
Products